Skip to content
AnalystLens

GILEAD SCIENCES, INC. 8-K Report, Executive Changes (Mar 14, 2024)

Reports
Leadership Changes
Filing Date
Filed March 14, 2024
Period End
March 10, 2024
Security
GILD
In the record · 2016–202610-K1210-Q328-K117

GILD filed 12 annual reports (10-K), 32 quarterly reports (10-Q) and 117 current reports (8-K) between 2016 and 2026.

  1. Leadership change8-K · Dec ’18Dec ’18
  2. Deal closed8-K · Jan ’21Jan ’21
  3. Leadership change8-K · Jul ’22Jul ’22
  4. Material agreement8-K · May ’26May ’26

Summary

Summary of the 8-K filed March 14, 2024. Cited figures are marked; the original filing is the authoritative source.

Gilead Sciences, Inc. (GILD) filed an 8-K report on March 14, 2024, to announce the upcoming retirement of a key board member.

Kevin E. Lofton, a member of the Board of Directors, has notified the company of his decision to retire, which will be effective at the conclusion of his term at the company's next annual meeting of stockholders on May 8, 2024. This transition appears to be planned and voluntary, as the filing explicitly states that Mr. Lofton's decision was not due to any disagreements with the Board or management.

Key Highlights

  1. Kevin E. Lofton to retire from Gilead's Board of Directors.
  2. Retirement effective at the Annual Meeting of Stockholders on May 8, 2024.
  3. Mr. Lofton's departure is voluntary and not a result of any disagreements.
  4. The filing is an 8-K Current Report, indicating a material event disclosure.
  5. No other significant operational, financial, or executive changes are detailed in this specific filing.

Frequently Asked Questions

  1. What is the main purpose of this 8-K filing?

    The primary purpose of this 8-K filing is to formally announce the retirement of a Board of Directors member, Kevin E. Lofton, and to comply with SEC regulations regarding the disclosure of significant corporate events.

  2. Is Kevin E. Lofton's departure a cause for concern?

    Based on the filing, Mr. Lofton's retirement is stated to be voluntary and not due to any disagreements with the Board or management. This suggests it is a planned transition rather than a result of internal conflict or performance issues.

  3. When will Kevin E. Lofton's retirement officially take effect?

    Mr. Lofton's retirement will be effective at the conclusion of Gilead Sciences, Inc.'s next annual meeting of stockholders, which is scheduled to be held on May 8, 2024.

  4. Are there any other significant executive or director changes mentioned in this filing?

    No, this particular 8-K filing focuses solely on the announced retirement of Kevin E. Lofton from the Board of Directors. No other executive or officer changes, or new appointments, are detailed in this report.